|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Article |
Promotes Diabetes in Nonobese Diabetic Mice by CD154-independent Antigen Presentation to CD8+ T Cells
Correspondence to: Richard A. Flavell, Section of Immunobiology, Yale University School of Medicine, Howard Hughes Medical Institute, 310 Cedar St., FMB 412, P.O. Box 208011, New Haven, CT 06520-8011. Tel:203-785-7024 Fax:203-785-7561 E-mail:fran.manzo{at}yale.edu.
Neonatal islet-specific expression of tumor necrosis factor (TNF)-
in nonobese diabetic mice promotes diabetes by provoking islet-infiltrating antigen-presenting cells to present islet peptides to autoreactive T cells. Here we show that TNF-
promotes autoaggression of both effector CD4+ and CD8+ T cells. Whereas CD8+ T cells are critical for diabetes progression, CD4+ T cells play a lesser role. TNF-
mediated diabetes development was not dependent on CD154CD40 signals or activated CD4+ T cells. Instead, it appears that TNF-
can promote cross-presentation of islet antigen to CD8+ T cells using a unique CD40CD154-independent pathway. These data provide new insights into the mechanisms by which inflammatory stimuli can bypass CD154CD40 immune regulatory signals and cause activation of autoreactive T cells.
Key Words:
TNF-
, CD154, diabetes, NOD mice, CD8+ cells
This article has been cited by other articles:
| TABLE OF CONTENTS |
|